# Comparative Glucose Clamp Study of Wockhardt's Recombinant Insulin Analog Glargine(Glaritus) With Lantus in T1DM

> **NCT01357603** · PHASE1 · COMPLETED · sponsor: **Wockhardt** · enrollment: 111 (actual)

## Conditions studied

- Type1 Diabetes

## Interventions

- **BIOLOGICAL:** Glargine

## Key facts

- **NCT ID:** NCT01357603
- **Lead sponsor:** Wockhardt
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2012-05
- **Final completion:** 2012-08
- **Target enrollment:** 111 (ACTUAL)
- **Last updated:** 2013-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01357603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01357603, "Comparative Glucose Clamp Study of Wockhardt's Recombinant Insulin Analog Glargine(Glaritus) With Lantus in T1DM". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01357603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
